{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptId=17&answer.dateOfAnswer=2019-06-14&uin=261092", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?answeringDeptId=17&answer.dateOfAnswer=2019-06-14&uin=261092", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptId=17&answer.dateOfAnswer=2019-06-14&uin=261092&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&answeringDeptId=17&answer.dateOfAnswer=2019-06-14&uin=261092", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptId=17&answer.dateOfAnswer=2019-06-14&uin=261092", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptId=17&answer.dateOfAnswer=2019-06-14&uin=261092", "items" : [{"_about" : "http://data.parliament.uk/resources/1130415", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1130415/answer", "answerText" : {"_value" : "

HIV pre-exposure prophylaxis (PrEP) is currently available through the three year, NHS England funded, PrEP impact trial, which is providing HIV prevention drugs to people at high risk of HIV infection. Expansion of the trial is underway across the country following the my Rt. hon. Friend Secretary of State for Health and Social Care\u2019s announcement in January that the trial would be expanded to 26,000 people. Participation in the trial is on a voluntary basis and it is for local authorities to decide whether they wish to take part. Work is now starting to consider future commissioning for PrEP after the trial has ended.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"} } , "answeringMemberConstituency" : {"_value" : "South Ribble"} , "answeringMemberPrinted" : {"_value" : "Seema Kennedy"} , "dateOfAnswer" : {"_value" : "2019-06-14", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-06-14T13:44:16.55Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-06-06", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "HIV Infection: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether his Department's policy is to ensure that HIV pre-exposure prophylaxis is available to all people who could benefit from it.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/230", "label" : {"_value" : "Biography information for Mr Ben Bradshaw"} } , "tablingMemberConstituency" : {"_value" : "Exeter"} , "tablingMemberPrinted" : [{"_value" : "Mr Ben Bradshaw"} ], "uin" : "261092"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 1, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }